CYP2C19*2 and *17 alleles have significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndrome - Cuisset, T; Loosveld, M; Morange, PE (JACC Cardiovasc Interven, 2012)
et al.